Conformationally restricted short peptides inhibit human islet amyloid polypeptide (hIAPP) fibrillization

51Citations
Citations of this article
43Readers
Mendeley users who have this article in their library.

Abstract

hIAPP fibrillization implicated in Type 2 diabetes pathology involves formation of oligomers toxic to insulin producing pancreatic β-cells. We report design, synthesis, 3D structure and functional characterization of dehydrophenylalanine (ΔF) containing peptides which inhibit hIAPP fibrillization. The inhibitor protects β-cells from hIAPP induced toxicity. © 2013 The Royal Society of Chemistry.

Cite

CITATION STYLE

APA

Mishra, A., Misra, A., Sri Vaishnavi, T., Thota, C., Gupta, M., Ramakumar, S., & Chauhan, V. S. (2013). Conformationally restricted short peptides inhibit human islet amyloid polypeptide (hIAPP) fibrillization. Chemical Communications, 49(26), 2688–2690. https://doi.org/10.1039/c3cc38982k

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free